Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Five-year cancer survival rate |
|---|---|
| Lymphatic and hemopoietic tissues | 138.4% |
| Lip | 75.2% |
| Bones, cartilage | 72.2% |
| Uterus | 70% |
| Breast | 68.4% |
| Ovary | 66.3% |
| Prostate | 65.6% |
| Bladder | 64.6% |
| Cervix | 64% |
| Melanoma | 62.7% |
| Larynx | 59.9% |
| Thyroid | 59.7% |
| Stomach | 58.7% |
| Colon | 55.5% |
| Rectum | 54.9% |
| Oral cavity | 53.9% |
| Kidney | 49.1% |
| Throat | 45.7% |
| Trachea, bronchus, and lung | 45.2% |
| Oesophagus | 39.7% |
| Connective, other soft tissues | 39.3% |
| Pancreas | 36.4% |
| Liver, bile ducts | 34.7% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Sources
Release date
June 2024
More information
Region
Russia
Survey time period
2023
Supplementary notes
The figures represent the share of patients registered with oncological establishments for five years or more since the malignant neoplasm diagnosis in the total number of registered patients at these establishments at the end of the year under consideration.
Citation formats
